Peer Review History: Virtual Screening of FDA Approved Drugs Library to Identify a Potential Inhibitor against NS2B-NS3 Protease of Yellow Fever Virus

Editor(s):

(1) Dr. Wenbin Zeng, Professor, Central South University, China.

(2) Dr. S. Prabhu, Sri Venkateswara College of Engineering, India.

(3) Dr. Vasudevan Mani, College of Pharmacy, Qassim University, Kingdom of Saudi Arabia.

Reviewers:

(1) V. Muralidharan, AMET University, India.

(2) Mostafa Abbas Shalaby, Cairo University, Egypt.

(3) Ali Reda Hussein, Thi-qar University, Iraq.

(4) P. Naresh, Vikas College of Pharmaceutical Sciences, India.

(5) B. Kavitha, Rayalaseema University, India.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (V. Muralidharan, India) | File 1 | File 2


Stage 2 | Peer review report_2 (Mostafa Abbas Shalaby, Egypt) | File 1 | NA


Stage 2 | Peer review report_3 (Ali Reda Hussein, Iraq) | File 1 | File 2


Stage 2 | Peer review report_4 (P. Naresh, India) | File 1 | NA


Stage 2 | Peer review report_5 (B. kavitha, India) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Stage 3 | Comment_Editor_3_v1 | File 1 | NA